Healthcare - Press Releases

Date	Title	Company
23-Feb-2022	Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab▼ and Golimumab Combination Therapy Versus Either Monotherapy Alone	Janssen
23-Feb-2022	The Majority of Adults with Moderately to Severely Active Crohn’s Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA®▼ (guselkumab)	Janssen
23-Feb-2022	Innovative solutions to the exploitation of health data in the global South	Warwick University
23-Feb-2022	CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021	Aoxin Q&M Dental Group Ltd
23-Feb-2022	miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study	miDiagnostics
23-Feb-2022	NHS gene testing does not detect half of people at cancer risk	The Institute of Cancer Research, London
23-Feb-2022	Lockdown doubled risk of mental distress on UK adolescents with previous mental health difficulties	UK Millennium Cohort Study
22-Feb-2022	Europe’s Only Parallel Trade Conference returns for its 16th Year	SMi Group
22-Feb-2022	MBMV invests in international bio-tech startup Arcensus GmbH	Arcensus GmbH
21-Feb-2022	Paul Archer promoted to Chief Commercial Strategy Officer, Envision Pharma Group	Envision Pharma Group
18-Feb-2022	QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM	Quotient Sciences
16-Feb-2022	Pain Therapeutics - Keynote Opening Addresses From The Pain Society And Eptiva Therapeutics	SMi Group
15-Feb-2022	FIRST CPD STANDARDS FOR HEALTHCARE COMMUNICATIONS PROFESSIONALS	Healthcare Communications Association
15-Feb-2022	mdgroup Appoints Steph Katz as Director of Seacole Health	mdgroup
15-Feb-2022	Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2022	CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST AND SKIN ANALYTICS EXPAND THEIR INNOVATION PARTNERSHIP	CW+
14-Feb-2022	4 Key Trends Driving Cancer Diagnostics Market Expansion Through 2027	Global Market Insights, Inc.
11-Feb-2022	Singapore study sheds light on antibiotics-associated diarrhea	Blue Totem Communications
10-Feb-2022	12 Ways To Use Infographics For Public Health	Top Pharma News
10-Feb-2022	PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference	PureTech